Multimodal AI and Radiomics for Cancer Precision Medicine
This special issue belongs to the section "Biosignal Processing".
Special Issue Information
Dear Colleagues,
Cancer precision medicine is undergoing a paradigm shift driven by advances in artificial intelligence (AI) and quantitative medical imaging. The integration of multimodal AI, radiomics, and advanced imaging techniques is transforming cancer diagnosis, prognosis, treatment planning, and response assessment.
This Special Issue, entitled “Multimodal AI and Radiomics for Cancer Precision Medicine”, aims to highlight recent advances in the development and application of AI-driven approaches that combine complementary imaging modalities, radiomic features, clinical information, and other relevant biomedical data to support personalized cancer care.
We invite researchers, clinicians, and data scientists to submit original research articles and comprehensive review papers addressing the current challenges and future directions in multimodal AI for oncology. We particularly welcome contributions that advance the integration of multimodal data and AI-driven approaches to improve cancer diagnosis, prognosis, treatment planning, and personalized patient care. Topics of interest include, but are not limited to, the following:
- Radiomic feature extraction and analysis of multimodal imaging data, and machine learning-based modeling.
- Integration of radiomics with clinical, genomic, and pathological data.
- Novel multimodal deep learning architectures for data fusion, including imaging, genomics, pathology, and clinical text.
- Multimodal AI for cancer classification, characterization, and treatment response prediction.
- Self-supervised, semi-supervised, and federated learning for multimodal cancer imaging applications, including cancer diagnosis, grading, and prediction.
- Multimodal AI for predicting treatment response, survival outcomes, and therapy-related toxicities.
- Large language models (LLMs) and multimodal foundation models for analyzing clinical reports and unstructured medical text, and integrating clinical text with medical imaging, radiomics, and other patient-level data for cancer diagnosis, prognosis, treatment planning, and personalized patient care.
- Explainable AI (XAI) and interpretability in multimodal oncological models.
- Tumor detection and segmentation.
The Special Issue will provide a platform for researchers and clinicians to present innovative computational methods and clinically relevant applications that advance precision medicine and improve cancer diagnosis and patient-specific treatment strategies.
Dr. Ahmed Sharafeldeen
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- multimodal artificial intelligence
- radiomics
- medical imaging analysis
- precision oncology
- deep learning
- machine learning
- explainable AI (XAI)
- digital pathology
- computer-aided diagnosis system
- treatment response
- tumor segmentation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

